Patent · US Active

Lyophilized pharmaceutical composition of Fc-peptide fusion protein

US10918698B2 · kind B2 · utility

0Cited by

1References

6Claims

0Family size

Assignee

Intas Pharmaceuticals Ltd. · IN

Inventors

Himanshu GADGIL · Sayla, IN
Chandresh CHHATBAR · Ahmedabad, IN
Vijaykant PANDEY · Ahmedabad, IN

Key dates

Filing date	Mar 24, 2015
Grant date	Feb 16, 2021
Priority date	—
Expiry date	Dec 5, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A novel and thermostable lyophilized pharmaceutical composition of Romiplostim (Fcpeptide fusion protein) along with buffer, bulking agent, stabilizer, and surfactant at pH range of 4.0-6.0.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.